Results 261 to 270 of about 152,115 (284)

Bevacizumab

Reactions Weekly, 2016
openaire   +2 more sources

Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer

Cancer Cell, 2020
Ying Shen, Xiaohong Wang, Junyan Lu
exaly  

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

Cancer Cell, 2021
Qing Zhou, Chongrui Xu, Ying Cheng
exaly  

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Nature Reviews Drug Discovery, 2004
Napoleone Ferrara, Hans-Peter Gerber
exaly  

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Lancet, The, 2007
Alain Ravaud, Sergio Bracarda, C?zary A Szczylik   +2 more
exaly  

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

New England Journal of Medicine, 2014
Mark R Gilbert, Terri S Armstrong, Jeffrey S Wefel   +2 more
exaly  

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

New England Journal of Medicine, 2014
Wolfgang Wick, Warren Mason, Frank Saran
exaly  

Bevacizumab

Reactions Weekly, 2014
openaire   +1 more source

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2011
Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald   +2 more
exaly  

Lomustine and Bevacizumab in Progressive Glioblastoma

New England Journal of Medicine, 2017
Wolfgang Wick, Felix Sahm, Alba Ariela Brandes   +2 more
exaly